Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?

The critical role of angiogenesis in tumor development makes its inhibition a valuable new approach in therapy, rapidly making anti-angiogenesis a major focus in research. While the VEGF/VEGFR pathway is the main target of the approved anti-angiogenic molecules in NSCLC treatment, the results obtain...

Descripción completa

Detalles Bibliográficos
Autores principales: Coelho, Ana Luísa, Gomes, Mónica Patrícia, Catarino, Raquel Jorge, Rolfo, Christian, Lopes, Agostinho Marques, Medeiros, Rui Manuel, Araújo, António Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503654/
https://www.ncbi.nlm.nih.gov/pubmed/26950275
http://dx.doi.org/10.18632/oncotarget.7794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503654/
https://www.ncbi.nlm.nih.gov/pubmed/26950275
http://dx.doi.org/10.18632/oncotarget.7794

Ejemplares similares